Amniotic Membrane Market Analysis Report 2021 key Insights: Smith & Nephew, Applied Biologics, Organogenesis Holdings, Osiris Therapeutics

Rising number of ophthalmology surgeries in geriatric population is expected to drive growth of the global amniotic membrane market during the forecast period. For instance, according to the Centers for Medicare and Medicaid Services (CMS), in 2017, over 50.7 million people in the U.S. were above 65 years of age meanwhile the total number of glaucoma surgeries performed were approximately 174,788. Amniotic membrane transplantation is used in glaucoma surgeries to prevent inflammation as these membranes lack immunogenicity and cannot be recognized by the immune system of human body. Hence, growing number of glaucoma surgeries is expected to fuel the growth of amniotic membrane market.

The Amniotic Membrane Market has accounted for US$ 3,201.1 Mn in 2020, and is expected to reach US$ 7,438.2 Mn by 2028, growing at a CAGR 12.8% during the forecast period 2021 to 2028.

Download PDF Sample Report @
https://www.coherentmarketinsights.com/insight/request-pdf/4477

Market players are engaged in inorganic activities such as partnership, merger and acquisitions, this is expected to drive growth of the amniotic membrane market. For instance, in November 2018, Generex Biotechnology Corporation, a biotechnology company, acquired 51% stakes of Olaregen Therapeutix Inc., a regenerative medicine company based in New York, this acquisition is expected to help the company to expand its product portfolio.

Major Market Competitors

Smith & Nephew, Applied Biologics, Organogenesis Holdings Inc., Osiris Therapeutics, Inc., Alliqua BioMedical, Inc., Amnio Technology, LLC, Next Biosciences, Integra LifeSciences, MiMedx, LifeCell International, Human Regenerative Technologies, LLC, Amniox Medical, Inc, Skye Biologics Inc., Wright Medical, TissueTech, Katena Products, Inc., NuVision Biotherapies, Surgenex, and Ventris Medical

COVID-19 outbreak was first reported on December 31, 2019 in Wuhan, China. According to the Coronavirus (COVID-19) Weekly Epidemiological Update by the World Health Organization, over 169 million cases and 3.5 million deaths have been reported due to Coronavirus (COVID-19) up till May 30, 2021 across the globe.

The COVID-19 pandemic has affected several markets across the globe and is also expected to hamper the global amniotic membrane market. The COVID-19 pandemic has affected the demand and supply of healthcare products in three main ways; by directly affecting the production and demand; by creating disruptions in distribution channels; and due to its financial impact on firms and financial markets. Many ophthalmology surgeries are currently at halt due to COVID-19 crisis in order to ensure safety of the patients. For instance, according to a news article published by the Times of India on October, 2020, many cataract surgeries were at total halt during the nationwide lockdown period in India.

According to the National Centre for Biotechnology Information, coronavirus can cause ocular infections, a meta-analysis study by Nasiri et al. in 2020 shows that 11.03% of COVID-19 patients in China reported ocular manifestations, with conjunctivitis being the most common ocular disease. As the number of cases of coronavirus infection increase, a rise in COVID-19 ocular manifestations has been observed during the study. This is expected to fuel the market growth of amniotic membrane market as these membranes are widely used in management of ocular manifestations.

For Customization on this Report @
https://www.coherentmarketinsights.com/insight/request-customization/4477

Frequently Asked Questions?

What will the market size be in 2028?

What are the key factors driving the European market?

What are the challenges to market growth?

Who are the key players in the market?

What are the market opportunities and threats faced by the key players?

What will be the growth rate in 2028?

Which strategies are used by top players in the Amniotic Membrane Market?

Buy This Complete A Business Report:
https://www.coherentMarketinsights.com/promo/buynow/4477

Contact us:
Mr. Shah
Senior Client Partner – Business Development
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
sales@coherentMarketinsights.com

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

This release was published on openPR.